Document Type : Short Communication


1 Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran

2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Pediatric Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran



Background: The rapid response of governments to overcome COVID-19 is increasingly important. In this study, we investigated the epidemiological changes of Covid-19 and the vaccination status of this disease in the Eastern Mediterranean Region (EMRO).
Methods: This research is a descriptive ecologic study. Data on vaccination status in the EMRO region were collected and Also the daily cases, daily COVID-19 mortality, the total number of deaths, and cases from January 3, 2020, to June 13, 2022.
Results: Iran had the highest number of known cases and deaths, while Bahrain and Tanzania had the highest cumulative rates of cases and deaths, respectively. The highest average monthly incidence rate changes were observed in Iraq, with 41.74%. Iran had the highest average monthly death rate changes with 25.75% and the highest number of known cases and deaths.The United Arab Emirates had the highest total vaccinations per 100 individuals and the highest percentage of persons fully vaccinated.
Conclusion: It appears that cooperation among countries in the region regarding vaccination can lead to a decline in the disease and ultimately control its spread. Furthermore, there is a noticeable decrease in the percentage of monthly changes after the start of vaccination in the EMRO countries. The gradual increase in some countries during the last segment highlights the importance of booster vaccinations.


  1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020;395(10223):470-3. doi: 1016/S0140-6736(20)30185-9.
  2. Yoo JH. The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just Begun. Journal of Korean medical science. 2020;35(4):e56. doi: 3346/jkms.2020.35.e56.
  3. Kamel Boulos MN, Geraghty EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. International journal of health geographics. 2020;19(1):8. doi: 1186/s12942-020-00202-8.
  4. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents. 2020;55(3):105924. doi: 1016/j.ijantimicag.2020.
  5. Schwartz DA. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of pathology & laboratory medicine. 2020;144(7):799-805. doi: 5858/arpa.2020-0901-SA.
  6. Liao H, Marley G, Si Y, Wang Z, Xie Y, Wang C, et al. A Tempo-geographic Analysis of Global COVID-19 Epidemic Outside of China. medRxiv. 2020:2020.03.20.20039602. doi: 10.1101/2020.03.20..
  7. Alaran AJ, Adebisi YA, Badmos A, Khalid-Salako F, Ilesanmi EB, Olaoye DQ, et al. Uneven power dynamics must be levelled in COVID-19 vaccines access and distribution. J Public Health in Practice. 2021;2:100096. doi: 10.1016/j.puhip.2021.
  8. Johnson AG. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron variant emergence-25 US Jurisdictions, April 4–December 25, 2021. MMWR Morbidity and mortality weekly report. 2022;71.
  9. Scobie HM, Johnson AG, Suthar AB, Severson R, Alden NB, Balter S, et al. Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status—13 US jurisdictions, April 4–July 17, 2021. Morbidity and Mortality Weekly Report. 2021;70(37):1284. doi: 10.15585/mmwr.mm7037e1. PMID: 34529637; PMCID:PMC8445374.
  10. Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D, et al. BNT162b2 vaccine booster and mortality due to Covid-19. New England Journal of Medicine. 2021;385(26):2413-20. doi: 10.1056/NEJMoa2115624.
  11. Niroomand N, Bayati M, Seif M, Delavari S, Delavari S. Self-medication pattern and prevalence among Iranian medical sciences students. Current Drug Safety. 2020;15(1):45-52. doi: 2174/1574886314666191022095058.
  12. Hagens A, İnkaya AÇ, Yildirak K, Sancar M, van der Schans J, Acar Sancar A, et al. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey. Vaccines. 2021;9(4):399. doi: 3390/vaccines9040399.